- conflicts or gaps
- [[{"field": "founders", "conflict": "YC lists Robert McBride, Vivek Mutalik, and Paul Turner; Crunchbase and company press also name Natalie Ma as co-founder; Tracxn lists only McBride and Turner.", "source_urls": ["https://www.ycombinator.com/companies/felix-biotechnology", "https://www.crunchbase.com/organization/felix-biotechnology", "https://tracxn.com/d/companies/felix-biotechnology/__cOl-kkoA-0askXlmcXz3INCSmQ7MwuyS5n5EZW8C4h8", "https://www.prnewswire.com/news-releases/felix-biotechnology-awarded-competitive-grant-from-the-national-science-foundation-to-power-phage-engineering-platform-301368609.html"]}, {"field": "headquarters", "conflict": "YC/YC-OSS report San Francisco; press releases use South San Francisco; Tracxn reports Daly City.", "source_urls": ["https://www.ycombinator.com/companies/felix-biotechnology", "https://www.prnewswire.com/news-releases/felix-biotechnology-awarded-competitive-grant-from-the-national-institutes-of-health-to-power-phage-engineering-platform-301586390.html", "https://tracxn.com/d/companies/felix-biotechnology/__cOl-kkoA-0askXlmcXz3INCSmQ7MwuyS5n5EZW8C4h8"]}, {"field": "funding.total", "conflict": "Tracxn reports $150K total across 6 rounds; individually sourced grants/awards alone exceed $2.3M.", "source_urls": ["https://tracxn.com/d/companies/felix-biotechnology/__cOl-kkoA-0askXlmcXz3INCSmQ7MwuyS5n5EZW8C4h8", "https://cysticfibrosisnewstoday.com/news/cf-foundation-invests-1-million-support-felix-biotech-phage-therapy/", "https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=R41AI165185&arg_ProgOfficeCode=104"]}, {"field": "funding.R41AI165185", "conflict": "HHS TAGGS lists $484,424 for award R41AI165185; VentureRadar lists $300,000 for a July 22, 2022 SBA/NIH award with the same project title.", "source_urls": ["https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=R41AI165185&arg_ProgOfficeCode=104", "https://www.ventureradar.com/organisation/Felix%20Biotechnology/a800f7d7-168e-4100-8690-ca51ce22aa18"]}, {"field": "products.YPT-01.compassionate_use_patients", "conflict": "TechCrunch (Mar 2020) and Falling Walls report 10 patients; Microbiome Times (2021) reports 12 patients via emergency INDs.", "source_urls": ["https://techcrunch.com/2020/03/21/yc-startup-felix-wants-to-replace-antibiotics-with-programmable-viruses/", "https://falling-walls.com/people/felix-biotechnology", "https://www.microbiometimes.com/felix-biotechnology-announces-initiation-of-the-cyphy-phase-1-2-study-at-yale-for-its-lead-asset-targeting-p-aeruginosa-infections/"]}, {"field": "funding.undisclosed_investors", "gap": "Illumina Accelerator and Point72 Ventures cited as funders; no public investment amounts or round dates found.", "source_urls": ["https://www.prnewswire.com/news-releases/felix-biotechnology-awarded-competitive-grant-from-the-national-institutes-of-health-to-power-phage-engineering-platform-301586390.html"]}, {"field": "funding.series_a", "gap": "Falling Walls (2022) states Felix was seeking tranched Series A; no public confirmation that Series A closed.", "source_urls": ["https://falling-walls.com/people/felix-biotechnology"]}, {"field": "employees", "gap": "Last reported team size is 6 (YC); headcount at shutdown not publicly reported.", "source_urls": ["https://www.ycombinator.com/companies/felix-biotechnology", "https://biopharmguy.com/company.php/Felix%20Biotechnology"]}, {"field": "intellectual_property", "gap": "Core phage-therapy IP appears licensed from Yale University; Felix ownership of patents not confirmed in public patent records.", "source_urls": ["https://ventures.yale.edu/yale-technologies/felix-biotechnology", "https://www.microbiometimes.com/felix-biotechnology-announces-initiation-of-the-cyphy-phase-1-2-study-at-yale-for-its-lead-asset-targeting-p-aeruginosa-infections/"]}]]
- source urls
- ["https://biopharmguy.com/company.php/Felix%20Biotechnology", "https://cysticfibrosisnewstoday.com/news/cf-foundation-invests-1-million-support-felix-biotech-phage-therapy/", "https://falling-walls.com/people/felix-biotechnology", "https://nsf.elsevierpure.com/en/projects/sbir-phase-leveraging-machine-learning-to-enable-generalized-phag/", "https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=R41AI165185&arg_ProgOfficeCode=104", "https://techcrunch.com/2020/03/21/yc-startup-felix-wants-to-replace-antibiotics-with-programmable-viruses/", "https://tracxn.com/d/companies/felix-biotechnology/__cOl-kkoA-0askXlmcXz3INCSmQ7MwuyS5n5EZW8C4h8", "https://ventures.yale.edu/yale-technologies/felix-biotechnology", "https://www.businesswire.com/news/home/20201105006041/en/TFF-Pharmaceuticals-and-Felix-Biotechnology-Sign-Letter-of-Intent-for-a-Collaboration-Development-and-License-Agreement", "https://www.crunchbase.com/organization/felix-biotechnology", "https://www.microbiometimes.com/felix-biotechnology-announces-initiation-of-the-cyphy-phase-1-2-study-at-yale-for-its-lead-asset-targeting-p-aeruginosa-infections/", "https://www.prnewswire.com/news-releases/cystic-fibrosis-foundation-invests-in-felix-biotechnology-as-they-advance-new-therapies-targeting-chronic-infections-in-cystic-fibrosis-301495037.html", "https://www.prnewswire.com/news-releases/felix-biotechnology-awarded-competitive-grant-from-the-national-institutes-of-health-to-power-phage-engineering-platform-301586390.html", "https://www.prnewswire.com/news-releases/felix-biotechnology-awarded-competitive-grant-from-the-national-science-foundation-to-power-phage-engineering-platform-301368609.html", "https://www.prnewswire.com/news-releases/felix-biotechnology-to-collaborate-with-animalbiome-on-a-novel-solution-for-pet-diarrhea-301461382.html", "https://www.ventureradar.com/organisation/Felix%20Biotechnology/a800f7d7-168e-4100-8690-ca51ce22aa18", "https://www.ycombinator.com/companies/felix-biotechnology", "https://yc-oss.github.io/api/batches/winter-2020/felix-biotechnology.json"]